Altre lingue McKesson Corporation

Azioni

MCK

US58155Q1031

Prodotti farmaceutici

Tempo reale stimato Cboe BZX Altri mercati azionari 22:07:56 13/01/2026			Variaz. 5gg	Var. 1 gen.
825,50 ^USD	-0,01%		-0,36%	+0,40%

20:01	MCKESSON CORPORATION : da Baird è Buy	ZM
19:50	McKesson Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 09:45 AM

Altre lingue

12/01	AOP Health's Rapiblyk Now Accessible Via Leading US Healthcare Improvement Companies
05/01	Drug Distributors Poised for Growth Amid Emerging Risks, BofA Says
22/12	Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date
18/12	Medline mit starkem Debüt an der Wall Street - Größter US-Börsengang seit 2021
17/12	BioMarin Pharmaceutical Inc. Appoints Rashmi Ramchandani as Chief Accounting Officer, Effective January 19, 2026
17/12	Medline soars 41% in Nasdaq debut after 2025's biggest IPO
08/12	TempraMed Technologies Ltd. Announces Strategic Agreement with Maccabi Healthcare Services
24/11	Iterum Therapeutics Plc's ORLYNVAH Now Available At McKesson
19/11	FiscalNote Holdings, Inc. Continues Global Momentum Amid Ongoing PolicyNote Adoption
10/11	McKesson Insider Sold Shares Worth $283,476, According to a Recent SEC Filing
07/11	McKesson : Second Quarter 2026 Transcript
06/11	McKesson : Q2 2026 McKesson Corporation Earnings Conference Call Transcript
06/11	McKesson : Q2 2026 McKesson Corporation Earnings Transcript
06/11	McKesson : Q2 2026 McKesson Corporation Earnings Conference Call Presentation
05/11	Healthcare firm McKesson's Q2 revenue slightly misses estimates
05/11	McKesson raises annual profit forecast on robust demand for specialty drugs
05/11	McKesson : Second Quarter 2026 Release
05/11	McKesson : Second Quarter 2026 Presentation
05/11	McKesson : Fiscal 2026 Second-Quarter Earnings Call Supplemental Slide Presentation
05/11	McKesson: Fiscal Q2 Earnings Snapshot
05/11	McKesson Fiscal Q2 Adjusted Earnings, Revenue Increase; Raises 2026 Earnings Outlook
05/11	(MCK) McKesson Expects Fiscal Year 2026 Adjusted EPS Range $38.35 - $38.85, vs. FactSet Est of $38.34
05/11	Earnings Flash (MCK) McKesson Post Q2 Revenue $103.15 Billion, vs. FactSet Est of $104.14 Billion
05/11	Earnings Flash (MCK) McKesson Posts Q2 Adjusted EPS $9.86, vs. FactSet Est of $9.03
05/11	McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS Guidance

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Articoli MarketScreener Analisi MarketScreener Idee di trading

Altre lingue McKesson Corporation

Azioni

MCK

US58155Q1031

Prodotti farmaceutici

Altre lingue

Filtri